EpiCare ERN Member on Muck Rack

EpiCare ERN Member

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with EpiCare ERN

Contact EpiCare ERN, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A de novo frameshift variant in MED13 gene in a patient with autism spectrum disorder and magnetic resonance imaging abnormalities mimicking tuberous sclerosis

|
By EpiCare ERN Member, Andrea Rossi, Gloria Pantalone, Maria Margherita Mancardi
| pericles.pericles-prod.literatumonline.com
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. REFERENCES , , , , , , , & (2012). An 800 kb deletion at 17q23.2 including the MED13 (THRAP1) gene, revealed by aCGH in a patient with a SMC 17. American Journal of Medical Genetics. Part A, 158A, 400–405. https://doi.org/10.1002/ajmg.a.34222 , , , , , , , , , , , , , , , , , , , … (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20(4), 602–611.
Open in Who Shared Issue with article?

Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis | Journal of Neurology

|
By Soto Insuga, Mid-Atlantic Epilepsy, EpiCare ERN Member, Universitari Vall d’Hebron
| link.springer.com
Abstract To assess the effectiveness and tolerability of brivaracetam (BRV) in adults with epilepsy by specific comorbidities and epilepsy etiologies. EXPERIENCE/EPD332 was a pooled analysis of individual patient records from several non-interventional studies of patients with epilepsy initiating BRV in clinical practice.
Open in Who Shared Issue with article?

Revisiting the concept of drug‐resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force

|
By Stéphane Auvin, Aristea S Galanopoulou, Solomon L Moshé, EpiCare ERN Member
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT S. Auvin is Deputy Editor for Epilepsia. He has served as consultant or given lectures for Angelini, Biocodex, Eisai, Encoded, Grintherapeutics, Jazz Pharmaceuticals, Neuraxpharm, Orion, Nutricia, Proveca, UCB Pharma, Vitaflo, Xenon, and Zogenix. He has been investigator for clinical trials for Eisai, Jazz Pharmaceuticals, Marinus, Proveca, Takeda, UCB Pharma, and Zogenix.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified